Skip to main content
Clinical Trials/NCT05549739
NCT05549739
Active, Not Recruiting
N/A

Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Hacettepe University1 site in 1 country30 target enrollmentSeptember 23, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Hacettepe University
Enrollment
30
Locations
1
Primary Endpoint
Respiratory muscle strength
Status
Active, Not Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.

Detailed Description

Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality. The study will evaluate respiratory parameters and functional capacity in coronary artery patients.

Registry
clinicaltrials.gov
Start Date
September 23, 2022
End Date
November 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dilara Saklica

Principal Investigator

Hacettepe University

Eligibility Criteria

Inclusion Criteria

  • Patients with coronary artery disease
  • Volunteering to participate in the research

Exclusion Criteria

  • Having a musculoskeletal problem
  • Having unstable cardiac disease
  • Having chronic heart failure (NYHA III-IV)
  • A history of acute coronary syndrome or surgical revascularization less than 3 months ago
  • Having arrhythmia
  • Having the last stage of kidney disease
  • Having active myocarditis or pericarditis

Outcomes

Primary Outcomes

Respiratory muscle strength

Time Frame: Day 1

Respiratory muscle strength will be evaluated using a mouth pressure device.

Respiratory muscle endurance

Time Frame: Day 1

Respiratory muscle endurance will be evaluated using a constant load test.

Six-minute-step test

Time Frame: Day 1

The number of steps the participant climbed up and down is recorded.

Secondary Outcomes

  • Functional Capasity(Day 1)
  • Pulmonary functions(Day 1)
  • Hand grip strength(Day 1)

Study Sites (1)

Loading locations...

Similar Trials